WallStreetZenWallStreetZen

NASDAQ: KROS
Keros Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Keros Therapeutics revenue was $244.06M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2025) ending on Dec 31, 2025 was $385.0k, down 97.3% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, KROS annual revenue was $244.1M, with 6,775% growth year-over-year.

KROS past revenue growth

How has KROS's revenue growth performed historically?

Company
6,774.96%
Industry
465.24%
Market
90.32%
KROS's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
KROS's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
KROS's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

KROS revenue history

Current Revenue
$244.1M
Current Earnings
$87.0M
Current Profit Margin
35.7%

Be the first to know when KROS announces revenue.

KROS Revenue History By Year

KROS Yearly RevenueKROS RevenueKROS ChangeKROS Revenue Growth
2025-12-31$244.06M$240.51M+6,774.96%
2024-12-31$3.55M$3.40M+2,250.99%
2023-12-31$151.00kN/AN/A
2022-12-31$0.00-$20.10M-100.00%
2021-12-31$20.10MN/AN/A
2020-12-31$0.00-$10.00M-100.00%
2019-12-31$10.00M$0.000.00%
2018-12-31$10.00MN/AN/A

1 of 1

Keros Therapeutics Revenue FAQ

What was KROS's revenue last quarter?

On Invalid Date, Keros Therapeutics (NASDAQ: KROS) reported Q4 2025 revenue of $385.00 thousand up 87.34% year over year. In the same quarter last year, Keros Therapeutics's revenue was $3.04 million.

What was Keros Therapeutics's revenue in 2025?

Keros Therapeutics's annual revenue for the twelve months ending Dec 31, 2025 was $244.06 million, a 6,774.96% increase year over year.

How much does Keros Therapeutics make in a day?

Based on Keros Therapeutics annual revenue for the past five years, KROS makes an average of $146,773.70 per day.

What was Keros Therapeutics's annual revenue growth in the past year?

As of Q1 2026, Keros Therapeutics's revenue has grown 6,774.96% year over year. This is 6,309.72 percentage points higher than the US Biotechnology industry revenue growth rate of 465.24%. Keros Therapeutics's revenue in the past year totaled $244.06 million.

How much does Keros Therapeutics make in a year?

Keros Therapeutics's revenue by year for the past five years is:
  • Keros Therapeutics's revenue for the twelve months ending Dec 31, 2025 was $244.06 million, a 6,774.96% increase year over year.
  • Keros Therapeutics's annual revenue for Dec 31, 2024 was $3.55 million, a 2,250.99% increase from 2023.
  • Keros Therapeutics's annual revenue for 2023 was $151.00 thousand, a Infinity% increase from 2022.
  • Keros Therapeutics's annual revenue for 2022 was $0.00, a 100% decrease from 2021.
  • Keros Therapeutics's annual revenue for 2021 was $20.10 million, a Infinity% increase from 2020.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.